Market Closed -
OTC Markets
02:41:42 2024-07-08 pm EDT
|
5-day change
|
1st Jan Change
|
0.0077
USD
|
-0.52%
|
|
0.00%
|
+71.11%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
4.829
|
9.253
|
2.737
|
6.709
|
1.731
|
0.565
|
Enterprise Value (EV)
1 |
6.096
|
10.21
|
3.585
|
7.892
|
3.151
|
2.434
|
P/E ratio
|
-5.33
x
|
-15.6
x
|
-4.51
x
|
-9.69
x
|
-2.11
x
|
-0.72
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
18
x
|
11.1
x
|
27.5
x
|
31.9
x
|
11.5
x
|
5.35
x
|
EV / Revenue
|
22.8
x
|
12.3
x
|
36.1
x
|
37.5
x
|
20.8
x
|
23
x
|
EV / EBITDA
|
-8.11
x
|
-208
x
|
-4.52
x
|
-11.1
x
|
-4.33
x
|
-
|
EV / FCF
|
350
x
|
-34.1
x
|
-10.3
x
|
-56.5
x
|
-14.3
x
|
-17.3
x
|
FCF Yield
|
0.29%
|
-2.93%
|
-9.66%
|
-1.77%
|
-6.98%
|
-5.78%
|
Price to Book
|
2.9
x
|
4.24
x
|
1.39
x
|
5.22
x
|
1.67
x
|
2.22
x
|
Nbr of stocks (in thousands)
|
92,863
|
99,713
|
99,713
|
114,396
|
125,557
|
125,557
|
Reference price
2 |
0.0520
|
0.0928
|
0.0274
|
0.0586
|
0.0138
|
0.004500
|
Announcement Date
|
4/1/19
|
3/30/20
|
3/31/21
|
3/31/22
|
4/10/23
|
4/8/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
0.2678
|
0.833
|
0.0994
|
0.2102
|
0.1512
|
0.1057
|
EBITDA
1 |
-0.7518
|
-0.0492
|
-0.7936
|
-0.7118
|
-0.7278
|
-
|
EBIT
1 |
-0.7604
|
-0.0571
|
-0.7958
|
-0.7133
|
-0.7292
|
-0.6705
|
Operating Margin
|
-283.97%
|
-6.85%
|
-800.3%
|
-339.25%
|
-482.45%
|
-634.38%
|
Earnings before Tax (EBT)
1 |
-0.9061
|
-0.5751
|
-0.6071
|
-0.6877
|
-0.8048
|
-0.7849
|
Net income
1 |
-0.9061
|
-0.5751
|
-0.6071
|
-0.6877
|
-0.8048
|
-0.7849
|
Net margin
|
-338.39%
|
-69.03%
|
-610.5%
|
-327.09%
|
-532.45%
|
-742.71%
|
EPS
2 |
-0.009757
|
-0.005931
|
-0.006088
|
-0.006054
|
-0.006527
|
-0.006251
|
Free Cash Flow
1 |
0.0174
|
-0.2989
|
-0.3465
|
-0.1397
|
-0.2201
|
-0.1407
|
FCF margin
|
6.5%
|
-35.88%
|
-348.43%
|
-66.45%
|
-145.59%
|
-133.17%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/1/19
|
3/30/20
|
3/31/21
|
3/31/22
|
4/10/23
|
4/8/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
1.27
|
0.95
|
0.85
|
1.18
|
1.42
|
1.87
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-1.685
x
|
-19.37
x
|
-1.069
x
|
-1.661
x
|
-1.95
x
|
-
|
Free Cash Flow
1 |
0.02
|
-0.3
|
-0.35
|
-0.14
|
-0.22
|
-0.14
|
ROE (net income / shareholders' equity)
|
-42.8%
|
-29.9%
|
-29.2%
|
-42.2%
|
-69.2%
|
-121%
|
ROA (Net income/ Total Assets)
|
-9.5%
|
-0.71%
|
-9.9%
|
-9.06%
|
-9.01%
|
-8.04%
|
Assets
1 |
9.536
|
81.44
|
6.134
|
7.591
|
8.93
|
9.758
|
Book Value Per Share
2 |
0.0200
|
0.0200
|
0.0200
|
0.0100
|
0.0100
|
0
|
Cash Flow per Share
2 |
0
|
0
|
-
|
0
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/1/19
|
3/30/20
|
3/31/21
|
3/31/22
|
4/10/23
|
4/8/24
|
|
1st Jan change
|
Capi.
|
---|
| +71.11% | 967K | | +9.21% | 32.74B | | +32.26% | 9.14B | | +13.32% | 8.13B | | +21.64% | 5.52B | | +14.76% | 3.77B | | +21.44% | 3.5B | | +1.31% | 3.38B | | -23.42% | 3.28B | | -12.28% | 2.64B |
Testing & Measuring Equipment
|